| Identification | Back Directory | [Name]
L-Prolinamide, N-[2-[4-[3-amino-6-(2-hydroxyphenyl)-4-pyridazinyl]-1-piperazinyl]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-, (4S)- | [CAS]
2380275-40-9 | [Synonyms]
L-Prolinamide, N-[2-[4-[3-amino-6-(2-hydroxyphenyl)-4-pyridazinyl]-1-piperazinyl]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-, (4S)- | [Molecular Formula]
C39H49N9O5S | [MOL File]
2380275-40-9.mol | [Molecular Weight]
755.93 |
| Chemical Properties | Back Directory | [Boiling point ]
1046.2±65.0 °C(Predicted) | [density ]
1.310±0.06 g/cm3(Predicted) | [storage temp. ]
4°C, stored under nitrogen, away from moisture | [solubility ]
DMSO : 100 mg/mL (132.29 mM; Need ultrasonic) | [form ]
Solid | [pka]
6.27±0.30(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Uses]
AU-16235 is an inactive epimer of AU-15330. AU-16235 has no effect on cancer cell survival and growth[1] | [Biological Activity]
AU-16235 is an inactive epimer of AU-15330. AU-16235 has no effect on cancer cell survival and growth[1] | [References]
[1]. Xiao L, et al. Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer. Nature. 2022;601(7893):434-439. |
|
|